MA15.02 Long-Term Safety and Clinical Activity Results From a Phase Ib Study of Erlotinib Plus Atezolizumab in Advanced NSCLC
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.440
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV